| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.3 |